0000899243-22-004132.txt : 20220202 0000899243-22-004132.hdr.sgml : 20220202 20220202160543 ACCESSION NUMBER: 0000899243-22-004132 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220131 FILED AS OF DATE: 20220202 DATE AS OF CHANGE: 20220202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Buckle Isabelle CENTRAL INDEX KEY: 0001823186 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36415 FILM NUMBER: 22583623 MAIL ADDRESS: STREET 1: C/O QUOTIENT LIMITED, B1, BUSINESS PARK STREET 2: TERRE BONNE, ROUTE DE CRASSIER 13 CITY: EYSINS STATE: V8 ZIP: 1262 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Quotient Ltd CENTRAL INDEX KEY: 0001596946 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 264719797 STATE OF INCORPORATION: Y9 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 28 ESPLANADE CITY: SAINT HELIER STATE: Y9 ZIP: JE2 3QA BUSINESS PHONE: 41274832286 MAIL ADDRESS: STREET 1: 28 ESPLANADE CITY: SAINT HELIER STATE: Y9 ZIP: JE2 3QA 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-31 0 0001596946 Quotient Ltd QTNT 0001823186 Buckle Isabelle C/O QUOTIENT LIMITED, B1, BUSINESS PARK TERRE BONNE, ROUTE DE CRASSIER 13 EYSINS V8 1262 SWITZERLAND 1 0 0 0 Ordinary Shares 2022-01-31 4 S 0 1961 D 24499 D Ordinary Shares 2022-01-31 4 M 0 6917 A 26460 D Ordinary Share Option (Right to Buy) 4.81 2030-09-01 Ordinary Shares 20790 20790 D Ordinary Share Option (Right to Buy) 4.81 2030-09-01 Ordinary Shares 2171 2171 D Ordinary Share Option (Right to Buy) 4.55 2030-10-31 Ordinary Shares 13611 13611 D Restricted Stock Units 2022-01-31 4 M 0 6917 0.00 D Ordinary Shares 6917 20751 D Ordinary Share Option (Right to Buy) 2.53 2031-10-31 Ordinary Shares 24040 24040 D Restricted Stock Units convert into ordinary shares on a one-for-one basis. 6,930 options vested on September 1, 2021 and remain exercisable, and the remaining 13,860 options will vest in two equal installments on September 1, 2022 and September 2, 2023. 724 options vested on October 31, 2021 and remain exercisable, and the remaining 723 options will vest on October 31, 2022. All 13,611 options have vested and remain exercisable. On October 31, 2021, the Reporting Person was granted 27,668 restricted stock units, of which 6,917 have vested and have converted into ordinary shares. The remaining 20,751 restricted stock units will vest in three equal installments on April 30, 2022, July 31, 2022 and October 31, 2022. The options vest and become exercisable on October 31, 2022. The sale reported on this Form 4 is a sale to cover taxes arising from the vesting and settlement of RSU awards. This sale is mandated by the Reporting Person's election to fund such taxes by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. /s/ Isabelle Buckle 2022-02-02